Data as-of 2026-08-14 close — every name in this cut carries a fresh bar this scan.

ABT overtook VEEV as the cut's highest RSI print this scan: 67.9 → 73.4 on +24.62% over 30 days, while VEEV's own regime cooled from "parabolic" to "breakout" even though its RSI stayed elevated at 73.1. MRK posted the cut's biggest single-scan gain, 54.7 → 69.0 (+14.3 points), with its regime upgraded to "breakout." ISRG and ZTS both cleared "collapse" this scan — both now read "downtrend" — while CVS climbed just clear of the oversold band it fell into last scan, 32.1 → 40.4. GH posted the sharpest reversal in the cut, 63.4 → 52.2 (-11.2 points), though its regime held at "uptrend" through the drop.

Source: healthcare.json (the broader universe, not the narrower healthcare-scan.json cut — consistent with the prior scan). Latest bar 2026-08-14 for every name in this cut. Prior scan: 2026-08-08-healthcare-scan.

ABT and VEEV swapped places at the top of the cut. ABT's RSI climbed from 67.9 to 73.4 on +24.62% over 30 days (change30d per healthcare.json), now the cut's highest print. VEEV, last scan's leader at 75.6, eased slightly to 73.1 — but the more notable move is underneath: its regime classifier cooled from "parabolic" to "breakout," a genuine structural cooldown rather than the price simply pausing.

MRK posted the cut's biggest single-scan RSI gain: 54.7 to 69.0 (+14.3 points) on +5.65% over the week and +9.89% over 30 days, with its regime upgrading from "uptrend" to "breakout." AMGN held just above the overbought line, easing slightly from 72.3 to 70.3.

ISRG and ZTS both cleared their "collapse" regime tags this scan, moving to "downtrend." ISRG's RSI climbed from 51.3 to 56.0 — the same relapse pattern visible in this session's biotech cut for the identical ticker — while ZTS moved from 39.6 to 46.0 on +1.56% over the week. Neither name is confirmed as structurally repaired, but the cut now carries zero names tagged "collapse," down from two last scan.

CVS climbed just clear of the oversold band it fell into last scan: RSI 32.1 to 40.4 (+8.3 points) on +1.53% over the week, though its 30-day return is still negative at -7.7%. MDT and ABT both crossed above RSI 70 this scan, joining VEEV and AMGN — but PFE (74.7 → 67.5) and TMO (71.6 → 63.2) both fell back below the line, so the overbought count held at four names even as the roster turned over completely on two of the four seats.

GH posted the sharpest single-name reversal in the cut: RSI 63.4 to 52.2 (-11.2 points) on a -6.69% week, though its regime classifier held at "uptrend" through the drop — no downgrade despite the size of the move.

• ABT overtook VEEV as the cut's highest RSI print. RSI 67.9 → 73.4 (+5.5), +24.6% over 30 days.
• VEEV's regime cooled from "parabolic" to "breakout." RSI eased slightly (75.6 → 73.1), but the regime downgrade is the bigger story.
• MRK posted the cut's biggest single-scan gain. RSI 54.7 → 69.0 (+14.3), regime upgraded to "breakout."
• ISRG and ZTS both cleared "collapse." ISRG and ZTS now both read "downtrend" — the cut has zero "collapse" names for the first time in several scans.
• CVS climbed just clear of the oversold band. RSI 32.1 → 40.4 (+8.3) — last scan's only sub-40 name, now clear of the line.
• MDT and ABT both crossed above RSI 70. MDT: 62.3 → 71.4. ABT: 67.9 → 73.4. PFE (74.7 → 67.5) and TMO (71.6 → 63.2) both fell back out — four overbought names again, but with two new occupants.
• GH posted the sharpest reversal in the cut. RSI 63.4 → 52.2 (-11.2), on a -6.7% week; regime held at "uptrend."
• No stale bars this scan — every name carries a fresh 2026-08-14 close.
• Universe unchanged. Same 22 tickers as the August 8 cut.

RSI measures how stretched a stock is over the past 14 sessions — under 30 is oversold, over 70 is overbought/extended. vs SMA20 is the price gap to the 20-day average. vs VWAP is the premium over the average price paid by current holders — a useful gut check on how much of a move is unrealized gain that could get sold into weakness. Trend combines direction/strength with a cross signal: GC (golden cross) is structurally healthier than DC (death cross). This scan's clearest signal is VEEV's regime downgrade from "parabolic" to "breakout" — the RSI itself barely moved, but the classifier's read on the underlying structure changed, which is a different (and arguably more useful) piece of information than the price number alone. Treat a regime change with a flat RSI as real information, not noise.

None.

None — CVS (40.4) climbed just clear of the line this scan, closing out a band that held one name last scan.

• Downtrend-regime tier: SYK, ISRG, ZTS — ISRG and ZTS both upgraded here this scan, out of "collapse."
• Pullback-regime tier: MDT, ABT, CVS, MRNA, HROW — mixed reads, MDT and ABT both extended above RSI 70 within this tier.
• Basing-regime tier: PFE, GILD — the cut's steadiest reads.
• Uptrend-regime tier: DXCM, LLY, BIIB, JNJ, UNH, VRTX, GH, XLV — the cleanest zone in the cut, 8 names.
• Breakout-regime tier: MRK, AMGN, TMO, VEEV — VEEV downgraded into this tier from "parabolic."

• ABT overtook VEEV as the cut's highest RSI print this scan — does it extend further, or does the move stall the way VEEV's did?
• VEEV's regime cooled from "parabolic" to "breakout" even as RSI stayed near 73 — is this the start of a real cooldown, or a one-scan pause?
• ISRG and ZTS both cleared "collapse" this scan — does either build on it, or does the damage resume (ISRG's relapse also visible in this session's biotech cut)?
• GH posted the cut's sharpest reversal while its regime held at "uptrend" — does the regime catch down to the tape, or does GH bounce back?

• Tape data (price/RSI/SMA/returns): full-scan pre-computed summaries as of the 2026-08-14 close — healthcare.